Shubhi Sehgal MD in Summit, Wisconsin

Additional Medical Specialties Include:
INTERNAL MEDICINE

Medical School: Sorry, her university is not listed
Graduation Year: 1996
The Primary Medical Specialty for Shubhi Sehgal MD is listed as: Endocrinology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 28
PAC (PECOS ID)#: 9032134044
NPI #: 1124006028
NPI Created On: 01/03/2006
NPI Last Updated Listed as: 11/22/2021
Primary Taxonomy Code: 207RE0101X
License Number:
4301076157
Listed Gender: Female

Forms of insurance accepted by include, but are not limited to:

• Humana
• Molina Healthcare of Wisconsin, Inc.
• Aspirus Arise Health Plan of Wisconsin, Inc.
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Punjabi, Hindi.

Services and Procedures include:

1. Blood glucose (sugar) test performed by hand-held instrument
2. Hemoglobin a1c level
3. Hemoglobin a1c level
4. Vaccine for influenza for injection into muscle
5. Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours
6. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
7. New patient office or other outpatient visit, typically 45 minutes
8. New patient office or other outpatient visit, typically 60 minutes
9. Established patient office or other outpatient visit, typically 15 minutes
10. Established patient office or other outpatient, visit typically 25 minutes
11. Established patient office or other outpatient, visit typically 40 minutes
12. Physician telephone patient service, 11-20 minutes of medical discussion
13. Physician telephone patient service, 21-30 minutes of medical discussion
14. Administration of influenza virus vaccine
15. Diabetes outpatient self-management training services, individual, per 30 minutes
16. Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic
17. Injection, denosumab, 1 mg